Precision BioSciences Inc expected to post a loss of $1.96 a share - Earnings Preview

Precision Biosciences

24/03/2025 12:42

Precision BioSciences Inc DTIL.OQ DTIL.O is expected to show a fall in quarterly revenue when it reports  results on March 26 for the period ending December 31 2024

The Durham North Carolina-based  company is expected to report a 39.3% decrease in revenue to $4.275 million from $7.04 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Precision BioSciences Inc is for a loss of $1.96 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Precision BioSciences Inc is $29.50​, above​ its last closing price of $5.45. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-2.23
-1.92
-2.25
Missed
-17
Jun. 30 2024
-1.68
-1.50
4.67
Beat
410.3
Mar. 31 2024
-2.01
-1.91
-0.35
Beat
81.7​
Dec. 31 2023
-3.99
-2.05
-4.06
Missed
-98.3
​​Sep. 30 2023
-5.03
-4.87
-2.10
Beat
56.9
Jun. 30 2023
-7.52
-7.32
-3.00
Beat
59​
Mar. 31 2023
-6.80
-6.78
-6.90
Missed
-1.8
Dec. 31 2022
-6.48
-6.22
-7.80
Missed
-25.3

This summary was machine generated March 24 at 12:42 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)